Akèy › Maladi Crohn › Pennsylvania › Philadelphia
Etid klinik pou Maladi Crohn nan Philadelphia, PA
13 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Ap rekriteFaz 3
- Thomas Jefferson University Hospital ( Site 5133), Philadelphia
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Ap rekriteFaz 2
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 265904, Philadelphia
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Children's Hospital of Philadelphia, Philadelphia
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2/3
- University of Pennsylvania, Philadelphia
- Jefferson Digestive Health Institute, Philadelphia
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Ap rekriteFaz 3
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Ap rekriteFaz 3
- Children's Hospital of Philadelphia (CHOP), Philadelphia
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Ap rekriteFaz 3
- Children's Hospital of Philadelphia, Philadelphia
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Children's Hospital of Philadelphia - Main /ID# 262197, Philadelphia
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Ap rekriteFaz 4
- Children's Hospital of Philadelphia, Philadelphia
Precise Infliximab Exposure and Pharmacodynamic Control
Ap rekriteFaz 2/3
- Nemours Children's Health System-Wilmington, Wilmington · 25 mi lwen
Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
Ap rekrite
- Children's Hospital of Philadelphia, Philadelphia
Etid Maladi Crohn nan lòt vil
- New York City, NY35 etid
- Boston, MA19 etid
- Miami, FL19 etid
- Cleveland, OH19 etid
- St. Louis, MO19 etid
- Tyler, TX17 etid
- Houston, TX17 etid
- Orlando, FL17 etid
- Atlanta, GA17 etid
- San Antonio, TX15 etid
- San Diego, CA15 etid
- Los Angeles, CA15 etid
Lòt etid nan Philadelphia
- Kansè (tout kalite)59 etid
- Kansè nan tete56 etid
- Kansè Poumon ki pa ti selil51 etid
- Kansè Metastatik46 etid
- Kansè pwostat44 etid
- Kansè kolorektal44 etid
- Kansè ovè44 etid
- Kansè poumon36 etid
- Leksemi mieloïd egi34 etid
- Ensifizyans kadyak31 etid
- Kansè Endomèt28 etid
- Depresyon26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.